Next Biosciences is thrilled to announce a strategic partnership with Adcock Ingram, leader in eye care in South Africa. This exciting collaboration will optimise efficiency and positively impact the distribution of our biological ophthalmology products: AmnioMatrix and OptiSerum.
Adcock Ingram will take charge of marketing and sales, leveraging their industry expertise and extensive market presence, while Next Biosciences will remain focused on manufacturing these unique biological products in our ISO13485 accredited laboratory.
We look forward to this exciting new chapter as we embark on this journey with Adcock Ingram. Together, we're redefining the landscape of eye care and paving the way for a brighter, clearer future.
A biological product widely used in eye surgery to support damaged tissue, protect, and shield defects and promote re-cellularisation.
A biological product, rich in growth factors which is used in the treatment of severe dry eyes and ocular surface diseases.